Skip to main content
logo
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.84
-0.53 (-3.24%)
At close: Jun 5, 2026, 4:00 PM EDT
15.82
-0.02 (-0.13%)
After-hours: Jun 5, 2026, 7:41 PM EDT

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,0372,1111,2651,2936153,238
Market Cap Growth
80.78%66.83%-2.16%110.39%-81.02%84.78%
Enterprise Value
1,7271,770970.951,025232.362,780
Last Close Price
15.8415.958.988.994.3222.87
PE Ratio
7.287.71224.50---
Forward PE
15.8619.6924.06---
PS Ratio
6.837.465.387.374.5971.01
PB Ratio
3.653.633.353.421.526.76
P/TBV Ratio
3.853.813.483.411.516.18
P/FCF Ratio
12.2215.5928.68---
P/OCF Ratio
12.2015.5628.50---
EV/Sales Ratio
5.796.254.135.841.7360.96
EV/EBITDA Ratio
11.2414.2365.79---
EV/EBIT Ratio
12.8616.87----
EV/FCF Ratio
10.3613.0722.01---
Debt / Equity Ratio
0.090.100.170.220.020.02
Debt / EBITDA Ratio
0.480.605.38---
Debt / FCF Ratio
0.410.551.80---
Net Debt / Equity Ratio
-0.55-0.56-0.74-0.67-0.94-0.95
Net Debt / EBITDA Ratio
-2.15-2.60-18.913.163.512.57
Net Debt / FCF Ratio
-1.86-2.39-6.337.404.782.90
Asset Turnover
0.400.430.430.340.260.09
Inventory Turnover
0.660.770.720.440.260.07
Quick Ratio
4.944.694.044.858.7411.85
Current Ratio
5.555.254.575.509.6012.63
Return on Equity (ROE)
51.91%59.91%1.52%-19.92%-24.46%-40.81%
Return on Assets (ROA)
37.63%40.54%-0.66%-18.13%-22.36%-36.05%
Return on Invested Capital (ROIC)
97.74%127.11%-2.61%-98.48%-270.54%-387.09%
Return on Capital Employed (ROCE)
19.22%18.89%-1.01%-20.48%-24.04%-38.69%
Earnings Yield
14.64%12.98%0.45%---
FCF Yield
8.18%6.42%3.49%---
Buyback Yield / Dilution
5.95%5.13%-2.07%-0.93%-9.70%-9.20%
Total Shareholder Return
5.95%5.13%-2.07%-0.93%-9.70%-9.20%
SEC Filings: 10-K · 10-Q